logo
Select company
Select metric
$ 2.54MCore Assets
VS
Market
5
Sector
12
Industry
17
History
80
$ 2.95Close
$ 1.1 - $ 13.42 52-Week Range
Ticker Information

Ticker

TRAW

Company Name

TRAWS PHARMA INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

TRAWS PHARMA INC - Core Assets Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

TRAW - Core Assets Historical data
DateTotal AssetsCash and EquivalentsCore AssetsGoodwill and Intangibles
6/30/2025$ 15.62M$ 13.08M$ 2.54M$ 0
3/31/2025$ 19.06M$ 15.94M$ 3.13M$ 0
12/31/2024$ 24.96M$ 21.34M$ 3.62M$ 0
9/30/2024$ 8.94M$ 5.41M$ 3.53M$ 0
6/30/2024$ 18.69M$ 16.89M$ 1.8M$ 0
3/31/2024$ 18.17M$ 16.39M$ 1.78M$ 0
12/31/2023$ 22.68M$ 20.82M$ 1.86M$ 0
9/30/2023$ 27.04M$ 25.24M$ 1.79M$ 0
6/30/2023$ 30.47M$ 29.73M$ 739K$ 0
3/31/2023$ 35.06M$ 34.22M$ 841K$ 0
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • TRAWS PHARMA INC's latest trailing twelve months (TTM) Core Assets stands at $ 1.01M.
  • Over the past 5 years, TRAWS PHARMA INC's average Core Assets has been $ 1.51M.
  • The median Core Assets for TRAWS PHARMA INC during this period was $ 1.09M
  • TRAWS PHARMA INC reached its highest Core Assets over the past 5 years at $ 3.62M.
  • The lowest Core Assets recorded by TRAWS PHARMA INC in the same timeframe $ 408K

TRAWS PHARMA INC's Core Assets vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Core Assets Benchmarks
CompanyCore Assets
CYCN : CYCLERION THERAPEUTICS INC $ 6.36MLGVN : LONGEVERON INC $ 4.09MBOLT : BOLT BIOTHERAPEUTICS INC $ 65.11MLYRA : LYRA THERAPEUTICS INC $ 20.8MXBIO : XENETIC BIOSCIENCES INC $ 573.85KBRTX : BIORESTORATIVE THERAPIES INC $ 6.38MTXMD : THERAPEUTICSMD INC $ 28.39MAPRE : APREA THERAPEUTICS INC $ 736.84KLPCN : LIPOCINE INC $ 12.53MTNON : TENON MEDICAL INC $ 3.22M

Definition of Core Assets

[Calculation] The core assets of a company represents the total [Assets] minus cash & equivalents [CashnEq] minus intangibles & goodwill [Intangibles].
Assets - Intangibles - CashnEq
(=) Core Assets
Core Assets for TRAWS PHARMA INC is calculated as follows: Assets [ $ 25.21M ] - Intangibles [ $ 0 ] - CashnEq [ $ 24.2M ]
(=) Core Assets [ $ 1.01M ]

TRAW - Core Assets, Last 5 years

$ 408K

Minimum

Dec 31, 2021

$ 3.62M

Maximum

Dec 31, 2024

$ 1.51M

Average

$ 1.09M

Median

Core Assets Benchmark Analysis

The chart above depicts the distribution of Core Assets for companies in the Total Stock Market. The average Core Assets of the companies is $ 803.6M with a standard deviation of $ 1.06B.
The following table provides additional summary stats:
Core Assets in the Market:
filtered constituents3.42K
min$ 0
max$ 4.42B
average$ 803.6M
median$ 289.12M
std$ 1.06B